- Home
- CWEN vs CNTA Comparison
CWEN vs CNTA Comparison
Compare CWEN & CNTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
HOLD
Current Price
$25.29
Company Overview
Basic Information| Metric | CWEN | CNTA |
|---|---|---|
| Founded | 2012 | 2020 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Electric Utilities: Central | Biotechnology: Pharmaceutical Preparations |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.9B | 3.7B |
| IPO Year | 2013 | 2021 |
Fundamental Metrics
Financial Performance| Metric | CWEN | CNTA |
|---|---|---|
| Price | $35.92 | $25.29 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 8 | 10 |
| Target Price | ★ $39.25 | $38.00 |
| AVG Volume (30 Days) | 1.2M | ★ 1.5M |
| Earning Date | 02-23-2026 | 11-05-2025 |
| Dividend Yield | ★ 4.93% | N/A |
| EPS Growth | ★ 125.75 | N/A |
| EPS | ★ 2.34 | N/A |
| Revenue | ★ $1,375,000,000.00 | $15,000,000.00 |
| Revenue This Year | $3.94 | N/A |
| Revenue Next Year | $14.18 | N/A |
| P/E Ratio | $15.24 | ★ N/A |
| Revenue Growth | 0.81 | ★ 118.88 |
| 52 Week Low | $24.50 | $9.60 |
| 52 Week High | $36.89 | $30.58 |
Technical Indicators
Market Signals| Indicator | CWEN | CNTA |
|---|---|---|
| Relative Strength Index (RSI) | 62.42 | 60.08 |
| Support Level | $31.81 | $21.50 |
| Resistance Level | $36.50 | $22.47 |
| Average True Range (ATR) | 1.16 | 1.08 |
| MACD | 0.37 | 0.38 |
| Stochastic Oscillator | 87.21 | 87.67 |
Price Performance
Historical Comparison CWEN
CNTA
About CWEN Clearway Energy Inc. Class C
Clearway Energy Inc is a publicly-traded energy infrastructure investor with a focus on investments in clean energy and owner of modern, sustainable and long-term contracted assets across North America. The company segments its operations into Flexible Generation, renewables and Corporate divisions.
About CNTA Centessa Pharmaceuticals plc
Centessa Pharmaceuticals PLC is a clinical-stage pharmaceutical company. The company's pipeline assets include: SerpinPC for Hemophilia A, B; LB101 for Solid Tumors; ORX750 for Narcolepsy Type 1 (NT1) and other sleep disorders; MGX292 Pulmonary Arterial Hypertension (PAH); and Undisclosed for Solid Tumors.